European conglomerate Thales is set to make its first significant investment in Israel.
The electronics, information systems, and medical equipment company offered to buy 50.1% of the share capital of CMT Medical Technologies Ltd. (EuroNext: CMD) at a price of €5.65 per share.
The transaction values CMT at €21.5 million. At a later stage, Thales will buy the remainder of the share capital.
CMT develops medical imaging systems. Its current market value is €8.7 million, so that the deal represents a premium of more than 100%.
The CMT board of directors recommended to accept the offer, filed with French authorities. The offer must be approved by shareholders.
Yokneam-based CMT develops and markets advanced digital X-ray imaging systems. It also operates a subsidiary in the US, CMT Medical Technologies Inc., which markets its products there.
CMT is headed by president and CEO Amit Meridor.
Published by Globes [online], Israel business news - www.globes-online.com - on December 18, 2008
© Copyright of Globes Publisher Itonut (1983) Ltd. 2008